iShares U.S. Healthcare ETF (IYH)
| 272.30 Delayed Data As of Jul 01 |  +3.38 / +1.26%Today’s Change | 247.38 Today|||52-Week Range 302.66 | -9.35% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped composed of U.S. equities in the healthcare sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
Latest IYH News
No recent news for iShares U.S. Healthcare ETF.
Performance
| 1 month | -2.37% | 3 years | +12.57% | |
| 3 months | -6.54% | 5 years | +11.56% | |
| 1 year | -0.57% | Since inception | +8.39% |
Data through 07/01/2022
Quote Details
| Previous close | $268.92 |
| Open day’s range | 266.94 – 272.56 |
| Net asset value (NAV) | 268.83 (06/30/2022) |
| Daily volume | 73,961 |
| Average volume (3 months) | 49,701 |
Data as of 3:59pm ET, 07/01/2022
Peer Comparisonvs. Health ETFs
| IYH | Category | |
|---|---|---|
| Performance 5-yr return | +11.56% | +11.31% |
| Expense Gross exp ratio | 0.41% | 1.01% |
| Risk 5 year sharpe ratio | 0.81 | 0.52 |
| Net assets | $2.9B | $1.9B |
| Average market cap | $120.9B | $43.0B |
| Average P/E | 22.6 | 22.2 |
| Dividend / Share | -- | 0.27% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.73% |
| Hardware | 0.15% |
| Business service | 0.12% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
Top 10 HoldingsPortfolio weighting
| JNJ Johnson & Johnson | 9.18% |
| UNH UnitedHealth | 9.07% |
| PFE Pfizer | 5.74% |
| LLY Eli Lilly and Co | 5.15% |
| ABBV AbbVie | 5.05% |
| MRK Merck | 4.52% |
| TMO Thermo Fisher Scientific Inc | 4.33% |
| ABT Abbott Laboratories | 3.96% |
| DHR Danaher Corp | 3.24% |
| BMY Bristol-Myers Squibb | 3.19% |
